𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Validation of cardiac123I-MIBG scintigraphy in patients with Parkinson’s disease who were diagnosed with dopamine PET

✍ Scribed by Kenji Ishibashi; Yuko Saito; Shigeo Murayama; Kazutomi Kanemaru; Keiichi Oda; Kiichi Ishiwata; Hidehiro Mizusawa; Kenji Ishii

Publisher
Springer
Year
2009
Tongue
English
Weight
245 KB
Volume
37
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation between cardiac 123I-MIBG an
Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy
✍ Phil Hyu Lee; Seung Hyeon Yeo; Hyun Joon Kim; Hyo Young Youm 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract We investigated an association between olfaction and cardiac ^123^I‐metaiodobenzylguanidine (MIBG) uptake in patients with Parkinson's disease (PD) and multiple system atrophy (MSA). There was a significant positive correlation between cardiac MIBG uptake and the Cross‐Cultural Smell Id

Analysis of the relationship between mus
Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease
✍ Kazumasa Shindo; Eri Kaneko; Harue Watanabe; Tetsuhiko Sugimoto; Emiko Ohta; Ken 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract To analyze the correlation between muscle sympathetic nerve activity (MSNA) and cardiac ^123^I‐metaiodobenzylguanidine (MIBG) uptake in patients with Parkinson's disease (PD), we measured both parameters in 14 PD patients who were 51 to 82 years of age (mean, 63.1 ± 8.7 years). The dura